MapLight Therapeutics ($MPLT) Insider Trading & Smart Money Activity
MapLight Therapeutics, Inc. ($MPLT) has 7 insider trades and 4 analyst ratings on file. In the last 12 months on the open market, no insider bought and 7 insiders sold ($1.26M), net -$1.26M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 7
- Net insider $ (12 mo)
- -$1.26M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 4
MPLT insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 1 · $192.66K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 6 · $1.06M | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All MPLT insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | James Woodruff LillieChief Scientific Officer | Sell (Open-market sale) | 11.51K sh | $93.03K | -5.48% | SEC | Read | ||||
| Insider | Christopher A. KroegerChief Executive Officer | Sell (Open-market sale) | 73.69K sh | $595.42K | -5.80% | SEC | — | ||||
| Insider | Anatol KreitzerChief Discovery Officer | Sell (Open-market sale) | 12.25K sh | $96.02K | -6.77% | SEC | Read | ||||
| Insider | Kristopher HansonGeneral Counsel | Sell (Open-market sale) | 9.02K sh | $72.88K | -6.58% | SEC | Read | ||||
| Insider | Jonathan GillisCAO and Interim CFO | Sell (Open-market sale) | 10.17K sh | $82.15K | -6.67% | SEC | Read | ||||
| Insider | Erin Pennock FoffChief Medical Officer | Sell (Open-market sale) | 15.36K sh | $124.07K | -4.92% | SEC | Read | ||||
| Insider | Hanson KristopherGeneral Counsel | Sell (Open-market sale) 10b5-1 | 16.51K sh | $192.66K | -5.5% | -32.5% | — | ||||
| Analyst | Raymond James | Reiterates to buy | PT $46 | +16.1% | -69.0% | Read | |||||
| Analyst | Craig-Hallum | Reiterates to buy | PT $40 | +25.1% | +23.0% | Read | |||||
| Analyst | Needham | Reiterates to buy | PT $42 | +15.1% | +18.5% | Read | |||||
| Analyst | Needham | Reiterates to buy | PT $42 | +15.1% | +18.5% | Read |
1W / 1M / 6M = how MPLT moved from the trade or filing date.
Insider trading in MPLT: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| James Woodruff Lillie | Chief Scientific Officer | 1 | -$93.03K | 198.60K | Oct 15, 2026 |
| Christopher A. Kroeger | Chief Executive Officer | 1 | -$595.42K | 1.20M | Oct 15, 2026 |
| Anatol Kreitzer | Chief Discovery Officer | 1 | -$96.02K | 168.68K | Oct 15, 2026 |
| Kristopher Hanson | General Counsel | 1 | -$72.88K | 128.02K | Oct 15, 2026 |
| Jonathan Gillis | CAO and Interim CFO | 1 | -$82.15K | 142.31K | Oct 15, 2026 |
| Erin Pennock Foff | Chief Medical Officer | 1 | -$124.07K | 296.91K | Oct 15, 2026 |
| Hanson Kristopher | General Counsel | 1 | -$192.66K | Sep 16, 2026 |
Analyst ratings on MPLT
Frequently asked questions
Are MPLT insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 7 insiders made 7 open-market sales worth $1.26M, a net -$1.26M.
What is the latest insider trade in MPLT?
James Woodruff Lillie, Chief Scientific Officer filed a sell (open-market sale) of 11.51K sh worth $93.03K on Oct 15, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.